Triiodothyronine + baicalein

Intervention

1 paper4 findings

  • 1 lab in 1 country
  • Funders: Anusandhan National Research Foundation and 4 more
  • Animals1

Outcomes

3

Dyslipidemia

downin mice1

1 study
  1. Triiodothyronine + baicalein decreases dyslipidemia in mice.

    “mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”

    Animalsadenine-induced CKD

    Bidirectional upregulation of Klotho by triiodothyronine and baicalein: mitigating chronic kidney disease and associated complications in aged BALB/c mice

    Biogerontology26 May 2025

More on Dyslipidemia

Renal fibrosis

downin mice1

1 study
  1. Triiodothyronine + baicalein decreases renal fibrosis in mice.

    “mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”

    Animalsadenine-induced CKDkidney

    Bidirectional upregulation of Klotho by triiodothyronine and baicalein: mitigating chronic kidney disease and associated complications in aged BALB/c mice

    Biogerontology26 May 2025

KL

upin mice1

1 study
  1. Triiodothyronine + baicalein increases KL in mice.

    “Combined T3 and BAI treatment significantly increased Klotho levels, surpassing individual effects”

    Animalsadenine-induced CKDkidney

    Bidirectional upregulation of Klotho by triiodothyronine and baicalein: mitigating chronic kidney disease and associated complications in aged BALB/c mice

    Biogerontology26 May 2025

More on KL

Associations

1

Cardiovascular disease

downin mice1

1 study
  1. Triiodothyronine + baicalein lowers the risk of cardiovascular disease in mice.

    “mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”

    Animalsadenine-induced CKD

    Bidirectional upregulation of Klotho by triiodothyronine and baicalein: mitigating chronic kidney disease and associated complications in aged BALB/c mice

    Biogerontology26 May 2025

More on Cardiovascular disease

Latest